Connection

CANDELARIA GOMEZ-MANZANO to Virus Replication

This is a "connection" page, showing publications CANDELARIA GOMEZ-MANZANO has written about Virus Replication.
Connection Strength

0.382
  1. Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cells. Cancer Gene Ther. 2010 Apr; 17(4):289-97.
    View in: PubMed
    Score: 0.065
  2. Robust infectivity and replication of Delta-24 adenovirus induce cell death in human medulloblastoma. Cancer Gene Ther. 2004 Nov; 11(11):713-20.
    View in: PubMed
    Score: 0.046
  3. Genetically modified adenoviruses against gliomas: from bench to bedside. Neurology. 2004 Aug 10; 63(3):418-26.
    View in: PubMed
    Score: 0.046
  4. The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models. Neuro Oncol. 2024 Aug 05; 26(8):1509-1525.
    View in: PubMed
    Score: 0.045
  5. An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus. Neuro Oncol. 2021 11 02; 23(11):1911-1921.
    View in: PubMed
    Score: 0.038
  6. Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens. PLoS One. 2016; 11(4):e0153814.
    View in: PubMed
    Score: 0.026
  7. Targeting brain tumor stem cells with oncolytic adenoviruses. Methods Mol Biol. 2012; 797:111-25.
    View in: PubMed
    Score: 0.019
  8. Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity. Cancer Gene Ther. 2009 Mar; 16(3):256-65.
    View in: PubMed
    Score: 0.015
  9. Adenovirus's last trick: you say lysis, we say autophagy. Autophagy. 2008 Jan; 4(1):118-20.
    View in: PubMed
    Score: 0.014
  10. ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo. Cancer Res. 2007 Sep 01; 67(17):8255-63.
    View in: PubMed
    Score: 0.014
  11. A novel CRM1-dependent nuclear export signal in adenoviral E1A protein regulated by phosphorylation. FASEB J. 2006 Dec; 20(14):2603-5.
    View in: PubMed
    Score: 0.013
  12. Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenoviruses. Neoplasia. 2005 Aug; 7(8):723-9.
    View in: PubMed
    Score: 0.012
  13. Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas. Neoplasia. 2005 Jan; 7(1):48-56.
    View in: PubMed
    Score: 0.012
  14. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene. 2000 Jan 06; 19(1):2-12.
    View in: PubMed
    Score: 0.008
  15. Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses. Exp Cell Res. 1999 Oct 10; 252(1):1-12.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.